Summary of Purpose
To determine the optimal dose of acetylsalicylic acid (ASA) that would minimize both the recurrence of noncardioembolic ischemic stroke and the risk of drug-related adverse events.Read More →
The following dates are available for this trial. Trial information last updated on 28 January 2010.
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- United Laboratory & Philippine Council for Health Research and Development
Double-blind, randomized, multicenter study.